LifeSci Partners: Founded in 2009, by Andrew McDonald PhD and Michael Rice, LifeSci Partners is a leading provider of strategic healthcare advisory services in the areas of Investor Relations, Communications, Venture Investing, Partnering & Analytics, Capital Market Services, Executive Search and On Demand Talent. With global presences in New York, Boston, San Francisco / Silicon Valley, Chicago, Charlotte, London, Geneva, Paris, Milan, and Tel-Aviv, LifeSci Partners leverages its relationships and local knowledge in multiple territories around the world to provide high value services for clients. To learn more, please visit us at https://www.lifescipartners.com


Lilly is a global healthcare leader that unites caring with discovery to create medicines that make life better for people around the world. We were founded more than a century ago by a man committed to creating high-quality medicines that meet real needs, and today we remain true to that mission in all our work. Across the globe, Lilly employees work to discover and bring life-changing medicines to those who need them, improve the understanding and management of disease, and give back to communities through philanthropy and volunteerism. To learn more about Lilly, please visit us at lilly.com and lilly.com/newsroom.



Merck & Co., Inc., Kenilworth, New Jersey, USA is known as MSD outside of the United States and Canada.

Merck has a strong history of success in translating cutting-edge research into life-saving medical breakthroughs. With more than 100 significant business development transactions since 2017, our team has experience working on collaborations from discovery through clinical-stage programs.

We believe that by working together we can play a major role in transforming global health care. Together we can invent for life. Learn more at msdlicensing.com.

The future of life sciences is in data, and no firm is better situated than MoFo to understand the convergence of the life sciences industry and data analytics. Our Life Sciences Group advises clients on all legal aspects of life sciences data analytics businesses, including patenting software and AI-related life science inventions, licensing of data, providing counsel on the steps to ensure data privacy and ethical use of data, and guiding clients through the FDA approval process for data-driven diagnostic assays and medical devices. Our Life Sciences Group is a unique amalgamation of lawyers with extensive training in biotechnology and pharmaceuticals coupled with the cutting-edge application of data science. We apply this combination for our digital health, biotechnology, medical device, pharmaceutical, and agtech clients, bridging the gap between the law and science. Learn more here


Perkins Coie has built a premier law firm by immersing ourselves in our clients’ technologies. Whether building strategic patent portfolios or prosecuting, guiding regulatory compliance, or defending and enforcing quality patents that consistently withstand challenges, we represent life sciences leaders and emerging innovators. We also help create new opportunities steering clients’ venture capital financings, IPOs, licensing agreements and other defining transactions. A number of our attorneys have advanced degrees in science or engineering.


Thermo Fisher Scientific Inc. (NYSE: TMO) is the world leader in serving science, with annual revenue exceeding $25 billion. Our Mission is to enable our customers to make the world healthier, cleaner and safer. Whether our customers are accelerating life sciences research, solving complex analytical challenges, improving patient diagnostics and therapies or increasing productivity in their laboratories, we are here to support them. Our global team of more than 75,000 colleagues delivers an unrivaled combination of innovative technologies, purchasing convenience and pharmaceutical services through our industry-leading brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services and Patheon. For more information, please visit www.thermofisher.com

Wilson Sonsini’s life sciences practice offers a multi-disciplinary team of attorneys, patent agents, and scientific advisors. Our professionals work with scientists, entrepreneurs, and investors who have helped develop innovative discoveries in nearly every field of medicine and healthcare, from genomics, immuno-oncology and pharmaceuticals, to diagnostics and synthetic biology. We represent clients in a wide range of strategic and operational corporate areas and help them with complex commercial and tech transactions driven by IP and innovation.



Amgen Business Development creates opportunities that leverage our unique capabilities with innovative technologies and therapies of our partners to deliver life changing therapies for patients with serious illnesses. By bringing together deep scientific, financial, deal, partnership, and integration expertise, Business Development plays a critical role in the execution of Amgen’s growth strategy and effectively manages the process of working with partners, from funding early-stage innovation to integration and alliance management once an agreement is executed. Resource Links


Halloran Consulting Group is a life science consulting firm that provides strategic regulatory, quality, clinical, and organizational support to industry leaders and startup visionaries in the pharmaceutical, biotechnology, and medical device sectors. Our consultants are subject matter experts who deliver a tailored approach to each engagement, successfully propelling our clients to their next inflection point. We connect clients with our trusted industry partners to drive operational excellence and innovation throughout their organizations. Our aim is to support our clients, and the patients they serve.


Daiichi Sankyo is a global pharmaceutical company with corporate origins in Japan. We provide innovative products and services in more than 20 countries around the world. With more than 100 years of scientific expertise, our company draws upon a rich legacy of innovation and a robust pipeline of promising new medicines to help patients. Through the outstanding knowledge and commitment of our 15,000 employees worldwide, we create innovative new and generic medicines, and new methods of drug discovery and delivery. We share a passion for innovation, as well as compassion for the patients around the world who are in need of our medicines.



JPMorgan Chase & Co. (NYSE: JPM) is a leading financial services firm based in the United States of America (“U.S.”), with operations worldwide. JPMorgan Chase had $3.7 trillion in assets and $280.7 billion in stockholders’ equity as of March 31, 2021. The Firm is a leader in investment banking, financial services for consumers and small businesses, commercial banking, financial transaction processing and asset management. Under the J.P. Morgan and Chase brands, the Firm serves millions of customers in the U.S. and globally many of the world’s most prominent corporate, institutional and government clients.

Learn more:

SMBC Group is one of the largest financial institutions headquartered in Japan. Sumitomo Mitsui Financial Group, Inc. (SMFG) is the holding company of SMBC Group. As of June 30, 2021, its total assets were $2.11 trillion. In the Americas, backed by the capital strength of SMBC Group and the value of its relationships in Asia, the Group offers a range of commercial and investment banking services to its corporate, institutional, and municipal clients.